Speaker | Title | Description | Recording |
Dr. Frank A Drews, PhD | An examination of human error in healthcare settings. What can we do to mitigate the risk? | Human error in hospitals is the third leading cause of death in the United States according to a 2016 study. Mistakes in medical care can be dangerous resulting in death or serious injury. Even the best clinicians can make errors, but what can be done to minimize them in patient care, especially when procedures are being completed by well-meaning but imperfect humans? This presentation will examine the common contributors to human error and while error is part of our cognitive makeup, research in healthcare settings will be reviewed that highlights steps that can be taken to mitigate or “engineer out” some of that risk. Dr. Drews examines the surprising impact of common occurrences in your everyday work life like interruptions, multi-tasking and time pressure that may contribute to error. | Watch now |
Michele Biscossi, ACNP-BC, MS, RN, CNL, VA-BC | Problem or Solution? Clinical Evidence connecting Needle-Free Connectors to Lower Rates of CLABSI and Occlusions | This presentation will look at types of evidence and why "real world studies" reporting actual clinical outcomes are more applicable to clinical practice decisions than laboratory studies. | Watch now |
Marc Stranz, PharmD
| Diving Deep into
| Choosing the appropriate vascular access device to meet the prescribed treatment and duration needs can be challenging. With literally hundreds of intravenous drugs, and no one published central list on known irritants, vesicants, and peripherally compatible infusates, making the right device decision is even more complex to navigate. Additionally, to utilize the GAVeCeLT DAV Expert APP and the MAGIC® APP one must have extensive foundational knowledge of non-cytotoxic infusates. What is an irritant or vesicant? What drugs fit into those categories? What do the guidelines provide for decision-making? This presentation describes the findings of a research project by three well known clinicians that initiated a review of manufacturer instructions for use and Gaharts 2021 Intravenous Medications for Infusion Complications. As a result, the Infusate Consideration Companion (ICC) tool was developed to assist with device selection and will be introduced and be made available during this session. | |
Elizabeth Morrell, DNP, RN, NEA-BC | Reducing risks and improving vascular access outcomes | This presentation will cover complications with SPC, areas to focus on when implementing a collaborative vascular access management team, change management and understanding the results of first-insertion success, dwell times and economic impact of short peripheral catheters. | |
Amanda Lynch BSN, RN, VA-BC Thomas Savage BSN, RN, CEN, CFRN | Implementing a Vascular Access Team (VAT) at a Rural Community Hospital | This presentation discusses how one hospital developed a vascular access team and conducted a study to demonstrate whether creating a VAT can led to better outcomes for patients through standardization of evidence-based practice, monitoring, and education, combined with an increased number of vascular access device options. | |
Megan Stuff, | Contrast enhanced CT: a comprehensive approach | This presentation focuses on implementing evidence-based best practices for contrast-enhanced CT procedures that may assist busy radiology departments achieve better outcomes and greater clinical efficiencies. | |
Michele Biscossi, ACNP-BC, MS, RN, CNL, VA-BC | Vascular Access Device Care and Management | An overview of the risks associated with VADs in clinical practice and review of how organizations need to evaluate VAD Care and Management against the INS Standards of best practice. A novel evidence-based data collection tool will be introduced which may help drive clinical decisions as they relate to VADS. | |
Cheryl Campos, DNP, RN-BC, CEN, CPHQ | Part 1 of a 2-part series: Implementation of Guidewire Peripheral IV Technology to Improve Care for DVA Patients in an Acute Care Hospital | Implementation of a special program to train nurses from various departments to identify difficult venous access (DVA) patients and successfully insert guide-wire assisted PIVs throughout the hospital to this compromised patient population. Part 1 of a 2-part series. | |
Cheryl Campos, DNP, RN-BC, CEN, CPHQ | Part 2 of a 2-part series: Implementing Guidewire Peripheral IV Technology Hospital Wide to Improve Patient Outcomes | A retrospective analysis following a special program for difficult venous access (DVA) patients. Clinically significant findings were identified including higher first-time attempt success rates, longer catheter dwell times, opportunities for cost savings and prevention of more invasive lines, when guide-wire assisted peripheral IV catheters were inserted by specialty trained nurses. Part 2 of a 2-part series. | |
Jon Bell, MSN, | Vascular Access in the Midst of COVID-19 | This presentation examines the impact of COVID-19 on vascular access policies and practices, and the opportunity that vascular access specialists have to emphasize evidence-based best practices in these challenging times. |
|
Labib Haddad, MD | The Importance of Peripheral IV Catheter Selection in the Quality and Safety of Cross-Sectional Imaging | Using evidence-based data, Dr.Haddad will discuss how to choose a safe and reliable venous access and review multiple imaging protocols while providing ample examples of real clinical situations. | |
Lynn Hadaway, MEd, RN, NPD-BC, CRNI | Mitigating the Risk of Extravasation with Power Injection | This presentation is based on a literature review and highlights a case study approach to discuss lawsuits involving contrast extravasation, including discussion on techniques for catheter assessment and new technology to reduce this serious complication. | |
Nadine Nakazawa, RN, BSN, VA-BC | Central Line Complications | Whether on insertion or post insertion, central lines carry some degree of risk for the patient. These risks can cause mortality and morbidity such as air embolism, pneumothorax, hemothorax, arterial puncture, thrombosis, and infection. As clinicians, it’s important to understand such risks to minimize negative consequences. This presentation will review central line risks, patient assessment, guidelines, and clinical literature. It will also discuss specific factors to consider in device selection and central line placement that promote the best patient outcomes possible. |
| Speaker | Title | Description | Recording |
Silvia Valero García | Developing HD Contamination Monitoring Guidelines: Global Perspectives | Since the U.S. National Institute for Occupational Safety and Health (NIOSH) Alert on Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings was released in 2004, there has been increased focus worldwide on HD safety. This educational activity will present experiences from practitioners globally as they have worked to develop guidelines and best practice recommendations for HD surface contamination monitoring. The faculty will discuss the process undertaken to develop the guidelines as well as highlight the specific recommendations made. | |
MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN | Safe to Touch: How Nursing and Pharmacy can Partner on HD Surface Contamination Monitoring | In 2020, the Safe to Touch Consensus Conference was convened to develop statements on HD surface contamination monitoring in healthcare settings. These consensus statements provide an opportunity for nursing and pharmacy to collaborate in development and implementation of to improve the safe handling and monitoring of HDs in the healthcare setting. This presentation will review the Safe to Touch Consensus Conference statements and provide a practical, multidisciplinary approach to implementation. | Watch Now |
BD Vascular Access Management is an integrated approach designed to identify and address gaps in the vascular access process that may result in improved clinical outcomes, better patient experiences, and process and economic efficiencies.
BD-24411 (12/21)
